Cleveland-Cliffs
CLF
$12.86
+4.89%
Cleveland-Cliffs Inc. is a vertically integrated North American flat-rolled steel producer and iron ore pellet manufacturer, operating through a single Steelmaking reportable segment that spans mined raw materials, direct reduced iron, ferrous scrap, primary steelmaking, and downstream stamping, tooling, and tubular finishing, with its largest end market in the automotive sector. As the largest flat-rolled steel producer in North America by volume, Cliffs occupies a scale-driven, blast-furnace-heavy position in the domestic industry, distinguishing it from electric-arc-furnace peers such as Steel Dynamics and Nucor through its integrated ore-to-metal model and heavy automotive contract exposure. The current investor narrative centers on a sharp cyclical inflection: after a brutal multi-quarter loss cycle, Q3 2026 delivered a return to profitability with revenue up 18.55% year over year, and management is guiding toward roughly $1 billion of incremental EBITDA from trade protections and contract renewals with a stated path to $4 billion by 2027. That recovery thesis is being tested against a still-negative trailing twelve-month earnings base, elevated leverage, and a stock that has swung violently between roughly $8 and $15 over the past six months, making this a high-beta, tariff-policy-sensitive cyclical turnaround debate rather than a steady compounder story.…
CLF
Cleveland-Cliffs
$12.86
Related headlines
Investment Opinion: Should I buy CLF Today?
Rating: Hold (accumulate selectively on weakness). The core thesis is that Cleveland-Cliffs has genuinely inflected — Q3 2026 net income of $152 million and EPS of $0.27 reversed Q2's -$145 million loss and Q1's -$237 million loss, with gross margin jumping from 3.73% to 8.29% — but the balance sheet (57.3% debt-to-capitalization, $148 million quarterly interest expense, only $77 million of cash) means the recovery must prove durable before the equity deserves a Buy. The analyst consensus of "hold" (2.77 mean across 10 analysts) with a $14.35 average target implies roughly 25% upside from $11.46, a gap that reflects value without conviction rather than a ringing endorsement.
Supporting evidence is concrete: revenue of $5.612 billion grew 18.55% year over year and marked a fourth consecutive sequential increase ($4.313B → $4.922B → $5.226B → $5.612B); Q3 EBITDA of $571 million annualizes above $2 billion against management's $1 billion incremental EBITDA guide and $4 billion 2027 path; the 0.351x PS and 1.07x P/B sit at the bottom of multi-year ranges (PS was 2.02x in Q4 2023 and 1.52x in Q4 2025); and the 6.72x forward PE on $1.6019 consensus EPS is not stretched versus integrated steel peers. The offsetting data are equally specific: TTM free cash flow of -$485 million, TTM net margin of -7.94%, ROE of -24.17%, and a 4.44 short ratio that amplifies moves in a stock with a 1.976 beta.
Three risks could invalidate the thesis: (1) the 8.29% gross margin proves a tariff-and-contract spike rather than a reset, pushing margins back toward Q1 2026's -1.67%; (2) automotive volume cuts hit a business where Steelmaking is $5.447 billion of $5.612 billion in revenue with no diversified offset; (3) liquidity stress forces another equity raise like the $951 million Q1 2026 issuance. This Hold would upgrade to Buy if gross margin holds above 8% for a second consecutive quarter and free cash flow turns sustainably positive, or if the stock pulls back toward the $9.38–$9.95 support zone; it would downgrade to Sell on a break below $9.38 or evidence that tariff protection is eroding. Verdict: fairly valued to modestly undervalued on forward earnings, but cheap on sales only because the market discounts durability — a cyclical value proposition, not a bargain.
Sign up to view all
CLF 12-Month Price Forecast
The forward view is genuinely two-sided: the operating inflection is real and the valuation sits at the bottom of its historical range, but the balance sheet leaves almost no cushion if the margin recovery stalls. The 50% base case assumes the recovery holds at a moderate level, delivering the $14.35 average target, while the 25/25 bull-bear split reflects the wide $12.00–$18.00 analyst range and the 20% two-day November drawdown that shows conviction is fragile. I would upgrade to bullish if gross margin holds above 8% for a second consecutive quarter alongside positive free cash flow, and downgrade to bearish if the stock breaks below $9.38 or if tariff protection visibly erodes. Until then, the risk/reward is balanced rather than compelling, which is consistent with the hold consensus and the 25% target upside that has not yet been marked down for the recent selloff.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Cleveland-Cliffs's 12-month outlook, with a consensus price target around $14.35 and implied upside of +11.6% versus the current price.
Average Target
$14.35
13 analysts
Implied Upside
+11.6%
vs. current price
Analyst Count
13
covering this stock
Price Range
$12 - $18
Analyst target range
Coverage is moderate with 10 analysts, and the distribution is decidedly cautious: 2 Buy, 10 Hold, and 1 Sell, yielding a consensus recommendation of "hold" and a recommendation mean of 2.77 on a scale where 3.0 is neutral. The average target price of $14.35 implies roughly 25% upside from the current $11.46, which is a meaningful gap for a hold-rated name and suggests targets have not yet been marked down following the early-November selloff. The consensus leans neutral-to-bearish in rating but mildly bullish in price target, a combination that typically signals analysts see value but lack conviction on timing and durability — consistent with a cyclical recovery that has delivered one good quarter but not yet a full-year track record. The target range of $12.00 to $18.00 is wide relative to the $11.46 price, with the low end only about 5% above spot and the high end implying roughly 57% upside, a spread that signals genuine disagreement about the earnings trajectory rather than consensus precision. The $18.00 high target likely assumes the full $1 billion incremental EBITDA materializes, automotive contract resets hold, tariff protections persist, and the $4 billion 2027 EBITDA path is achieved — essentially a multiple-expansion-plus-earnings-delivery scenario. The $12.00 low target appears to price in margin compression from high fixed costs, competitive share loss to lower-cost EAF producers like Steel Dynamics, and the risk that the Q3 profit proves a tariff-driven spike rather than a durable reset. Institutional ratings show a mild positive drift — Wells Fargo upgraded from Equal Weight to Overweight on October 6 and reiterated Overweight on October 20, B. Riley and GLJ Research maintain Buy, while Barclays remains Underweight and JPMorgan, Citigroup, and Morgan Stanley stay Neutral — indicating the sell side is slowly warming but not yet convinced, and the recent 20% two-day drawdown may force target revisions that the current $14.35 average does not yet reflect.
Bulls vs Bears: CLF Investment Factors
The bull case currently rests on a genuine inflection — Q3 2026 delivered $152 million of net income, 18.55% revenue growth, and a 456-basis-point sequential gross margin improvement — against a valuation at the very bottom of its historical PS and P/B ranges and analyst targets implying 25% upside. The bear case is equally concrete: 57.3% debt-to-capitalization, $148 million of quarterly interest expense, -$485 million TTM free cash flow, and only $77 million of cash mean the recovery must be durable, not just one good quarter, and the 20% two-day November drawdown shows the market is not yet convinced. On balance the evidence slightly favors the bulls on trajectory but the bears on balance-sheet safety, which is why the consensus is a 'hold' with a bullish price target — a classic value-without-conviction setup. The single most important tension is whether the Q3 margin recovery is a durable tariff-and-contract-driven reset or a temporary spike; if gross margin holds above 8% and the $1 billion incremental EBITDA materializes, the 0.351x PS re-rates sharply, but if it fades back toward breakeven, the leverage and cash position become acute.
Bullish
- Q3 swing to profitability is decisive: Q3 2026 net income of $152 million (EPS $0.27) reversed a Q2 loss of -$145 million and Q1 loss of -$237 million, with gross margin jumping from 3.73% to 8.29% in a single quarter. Operating income of $312 million versus -$207 million in Q1 shows the operating leverage inherent in the blast-furnace model is finally working in shareholders' favor.
- Revenue accelerating four straight quarters: Q3 2026 revenue of $5.612 billion grew 18.55% year over year and marked the fourth consecutive sequential increase from $4.313 billion in Q4 2025, $4.922 billion in Q1, and $5.226 billion in Q2. The roughly $300-400 million added per quarter implies a broadening pricing and demand recovery rather than a one-off spike.
- Trough valuation multiples with re-rating history: PS of 0.351x sits at the very bottom of a multi-year range that reached 2.02x in Q4 2023 and 1.52x in Q4 2025, while P/B of 1.07x is in the lower half of its band. Historically these trough readings preceded sharp re-ratings, and the 6.72x forward PE on $1.6019 consensus EPS is not stretched versus integrated steel peers.
- Analyst targets imply 25% upside: The $14.35 average target is roughly 25% above the $11.46 price, with a high of $18.00 implying 57% upside, and Wells Fargo upgraded to Overweight in October. The gap between a 'hold' consensus rating (2.77) and a meaningfully higher target suggests analysts see value but are waiting for confirmation of durability.
Bearish
- Balance sheet leverage is the core vulnerability: Debt-to-equity of 1.336 and total debt to capitalization of 57.3% leave little room for error, while $148 million of quarterly interest expense consumes about 26% of Q3's $571 million EBITDA. Free cash flow TTM is -$485 million despite Q3 turning positive at $72 million, and with only $77 million of cash (cash ratio 0.02) the company depends on revolver access and capital markets.
- Trailing profitability still deeply negative: TTM net margin is -7.94%, operating margin -7.29%, gross margin -4.10%, ROE -24.17%, and EPS -$0.226, meaning the trailing PE of -4.43 is meaningless and the entire valuation rests on forward estimates. An 8.29% gross margin is thin for a steelmaker and leaves almost no cushion if automotive volumes soften or scrap and ore costs rise.
- 20% two-day collapse signals fragile conviction: The stock fell from $14.14 on November 3 to $11.27 on November 5, a roughly 20% drawdown in two sessions, and is now down 4.98% over one month and 6.53% over three months. Three-month relative strength versus SPY is -1.62, meaning CLF is lagging a weak market, and the 4.44 short ratio amplifies downside moves.
- Single-segment concentration in autos: The Steelmaking segment generated $5.447 billion of Q3 revenue versus just $504 million from Other Businesses, so the entire thesis hinges on flat-rolled steel pricing and automotive contract resets. There is no diversified offset if auto production cuts or import competition pressure domestic volumes.
CLF Technical Analysis
CLF is in a choppy, range-bound recovery phase rather than a clean uptrend, with the stock up 13.58% over the past year but down 15.74% year to date, a wide divergence that reflects a violent boom-bust cycle within the twelve-month window. At $11.46, the stock sits at roughly 49% of its 52-week range of $7.73 to $15.35, placing it squarely in the middle of the band — neither a momentum breakout nor a capitulation low, which argues for patience and level-based entries rather than chasing. The 52-week high of $15.35 was set during the October earnings-driven spike, while the $7.73 low marked the summer trough, and the current mid-range position signals a market still undecided on whether the earnings recovery is durable. Recent momentum has deteriorated sharply: the stock is down 4.98% over the past month and 6.53% over three months, a deceleration that conflicts with the positive 13.58% one-year return and suggests the October rally is being unwound. The most striking recent action is the two-day collapse from $14.14 on November 3 to $11.27 on November 5 — a roughly 20% drawdown in two sessions — followed by a modest 1.69% bounce to $11.46, which points to heavy distribution and fragile conviction. Notably, CLF's one-month relative strength versus SPY is a barely positive 0.0149 while its three-month relative strength is -1.62, meaning the stock is merely keeping pace with a weak market rather than leading it, and the 4.44 short ratio alongside 16.8 million daily volume suggests meaningful short interest amplifying moves in both directions. Key technical levels are clear: support sits at the $9.38–$9.95 zone that held in late June and early July, with the ultimate floor at the $7.73 52-week low, while resistance is the $14.26–$15.35 October high band. A breakout above $15.35 would confirm the recovery thesis and likely trigger short covering, whereas a breakdown below $9.38 would signal the earnings recovery is being priced out and reopen the path toward single digits. With a beta of 1.976 — nearly double the market's volatility — position sizing must be materially smaller than a market-beta equivalent, and the -51.67% max drawdown underscores that this name can halve in a cycle.
Beta
1.98
1.98x market volatility
Max Drawdown
-51.7%
Largest decline past year
52-Week Range
$8-$15
Price range past year
Annual Return
+24.6%
Cumulative gain past year
| Period | CLF Return | S&P 500 |
|---|---|---|
| 1m | -0.9% | -3.7% |
| 3m | +5.0% | -2.9% |
| 6m | +17.7% | +0.2% |
| 1y | +24.6% | +10.1% |
| ytd | -5.4% | +10.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CLF Fundamental Analysis
The revenue trajectory has inflected decisively upward: Q3 2026 revenue of $5.612 billion grew 18.55% year over year versus $4.734 billion in Q3 2025, and marked the fourth consecutive sequential increase from $4.313 billion in Q4 2025, $4.922 billion in Q1 2026, and $5.226 billion in Q2 2026. The Steelmaking segment dominates at $5.447 billion of revenue versus just $504 million from Other Businesses, meaning the entire investment case hinges on flat-rolled steel pricing, automotive contract resets, and tariff-protected domestic volumes rather than any diversified offset. This accelerating top line is the clearest evidence that the cyclical trough has passed, and the sequential cadence — roughly $300–400 million added per quarter — implies the demand and pricing recovery is broadening rather than a one-quarter anomaly. Profitability has swung from deeply negative to positive in a single quarter: Q3 2026 net income was $152 million with a gross margin of 8.29% and operating income of $312 million, a dramatic reversal from Q2 2026's -$145 million loss and 3.73% gross margin, Q1 2026's -$237 million loss on a -1.67% gross margin, and Q4 2025's -$243 million loss on a -4.43% gross margin. The trailing twelve-month picture remains negative — net margin of -7.94%, operating margin of -7.29%, and gross margin of -4.10% — reflecting the drag of the prior three loss quarters, and ROE of -24.17% and ROA of -0.105% confirm capital is still being destroyed on a trailing basis. The key question is durability: an 8.29% gross margin is thin for a steelmaker and leaves little cushion if automotive volumes soften or scrap and ore costs rise, but the trajectory from negative to positive margins in one quarter is exactly the operating leverage bulls are paying for. The balance sheet is the weak link: debt-to-equity stands at 1.336 with total debt to capitalization at 57.3%, interest expense of $148 million per quarter consumes a large share of the $571 million Q3 EBITDA, and free cash flow TTM is -$485 million despite Q3 turning positive at $72 million. Liquidity is adequate with a current ratio of 1.95, but the quick ratio of 0.64 and cash ratio of 0.02 — with only $77 million of cash at period end — mean the company is critically dependent on operating cash flow and revolving credit access. Q3 operating cash flow of $224 million against $152 million of capex produced the $72 million FCF, and the Q1 2026 issuance of $951 million in common stock plus ongoing debt repayment ($383 million in Q3) shows management is actively deleveraging but still reliant on external capital markets to bridge the cycle.
Quarterly Revenue
$5.6B
2026-09
Revenue YoY Growth
+18.6%
YoY Comparison
Gross Margin
8.3%
Latest Quarter
Free Cash Flow
$-485000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CLF Overvalued?
Because trailing net income is negative (EPS of -$0.226 and a trailing PE of -4.43), the PE ratio is not meaningful and I am leading with the price-to-sales ratio of 0.351x and the EV/Sales of 0.718x as the primary valuation anchors, supplemented by the forward PE of 6.72x. The gap between the meaningless trailing PE and the 6.72x forward PE — built on consensus EPS of $1.6019 — is the entire valuation story: the market is pricing a full earnings recovery, and at 6.72x forward earnings the stock is cheap only if that $1.60 EPS estimate materializes. The price-to-book of 1.069x provides a secondary floor reference, while the negative EV/EBITDA of -83.7x and PCF of -14.15x simply reflect trailing losses and are not actionable. Against a steel sector where integrated producers typically trade at mid-single-digit to low-double-digit forward multiples, CLF's 6.72x forward PE is not obviously stretched, but its 0.351x PS ratio is well below the 1.0x–1.5x range the stock itself has historically commanded, implying the market discounts the sustainability of the margin recovery. The stock's own historical PS band is instructive: PS was 1.10x in Q3 2026, 1.03x in Q2 2026, 0.97x in Q1 2026, 1.52x in Q4 2025, and 2.02x back in Q4 2023, so the current 0.351x reading sits at the very bottom of its multi-year range — a level that historically coincided with trough sentiment and has preceded sharp re-ratings. Similarly, P/B of 1.07x compares to 1.09x in Q3 2026, 0.96x in Q2 2026, 0.82x in Q1 2026, and 1.31x in Q4 2023, placing book value valuation in the lower half of its range. The interpretation is binary: either the market is correctly pricing structural margin impairment from high fixed costs and automotive exposure, or it is offering a cyclical value opportunity at trough multiples — and the Q3 earnings inflection plus the $4 billion 2027 EBITDA target are the evidence that will resolve that debate.
PE
-4.4x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 3x~12x
vs. Industry Avg
21.1x
Industry PE ~21.1x*
EV/EBITDA
-83.7x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on a leveraged balance sheet that has almost no liquidity cushion. Debt-to-equity of 1.336 and total debt to capitalization of 57.3% are high for a cyclical steelmaker, and $148 million of quarterly interest expense absorbs roughly 26% of Q3's $571 million EBITDA, so a modest margin reversal quickly pressures coverage. Free cash flow TTM is -$485 million despite Q3 turning positive at $72 million, and with only $77 million of cash (cash ratio 0.02, quick ratio 0.64) the company depends on operating cash flow and revolver access; the Q1 2026 $951 million equity issuance shows management is already bridging the cycle with external capital. Revenue concentration compounds this: $5.447 billion of Q3's $5.612 billion came from Steelmaking, so a single end-market shock in automotive flows almost directly to EBITDA.
Market and competitive risks are dominated by valuation compression and the integrated-versus-EAF cost gap. At 0.351x PS the stock is cheap versus its own history, but that discount reflects a market that doubts the durability of an 8.29% gross margin, and if the multiple stays depressed the 6.72x forward PE on $1.6019 consensus EPS offers no protection against estimate cuts. Blast-furnace-heavy CLF carries structurally higher fixed costs than electric-arc-furnace peers like Steel Dynamics and Nucor, and recent coverage notes tariffs are widening the performance gap between flexible and high-fixed-cost producers. With a beta of 1.976, CLF moves roughly twice the market, and the 4.44 short ratio plus 16.8 million daily volume mean sector rotation or a tariff-policy headline can move the stock violently; the November 3-5 collapse from $14.14 to $11.27 is a live example.
Worst case, a rollover in automotive demand combined with fading tariff protection would push gross margin back toward the negative levels seen in Q1 2026 (-1.67%) and Q4 2025 (-4.43%), forcing another equity raise or asset action and re-pricing the stock toward its summer trough. The 52-week low of $7.73 and the analyst low target of $12.00 bracket the realistic downside: from $11.46, a move to $7.73 is roughly -33%, and the -51.67% historical max drawdown shows the name can halve in a cycle. A more moderate adverse path to the $9.38-$9.95 support zone implies about -13% to -18%, while a full de-rating to the 52-week low would cost an investor roughly a third of capital.
FAQ
Ranked by severity, the first risk is balance-sheet fragility: 57.3% debt-to-capitalization, $148 million of quarterly interest expense consuming roughly 26% of Q3's $571 million EBITDA, only $77 million of cash (cash ratio 0.02), and -$485 million TTM free cash flow mean a margin reversal quickly pressures liquidity and could force another equity raise like the $951 million Q1 2026 issuance. Second is end-market concentration: Steelmaking generated $5.447 billion of Q3's $5.612 billion in revenue, so automotive production cuts flow almost directly to EBITDA with no diversified offset. Third is competitive and policy risk: CLF's blast-furnace-heavy model carries structurally higher fixed costs than EAF peers like Steel Dynamics and Nucor, and recent coverage notes tariffs are widening that performance gap, so any erosion of Section 232-style protections would be doubly damaging. Fourth is market and volatility risk: a beta of 1.976, a 4.44 short ratio, and a -51.67% historical max drawdown mean the stock can halve in a cycle, as the roughly 20% two-day November 3-5 collapse from $14.14 to $11.27 demonstrated.
The 12-month forecast is split 50% base / 25% bull / 25% bear. The base case (50% probability) targets $12.00-$14.35, assuming consensus EPS of $1.6019 is roughly met, revenue holds near the $5.2-$5.6 billion quarterly run-rate, gross margin oscillates in the 5-8% band, and the stock gravitates toward the $14.35 analyst average with the $12.00 low target as the floor. The bull case (25%) targets $15.35-$18.00, requiring gross margin above 8% for a second consecutive quarter, the $1 billion incremental EBITDA landing, and a PS re-rating off the 0.351x trough toward 0.6-0.7x. The bear case (25%) targets $7.73-$12.00, driven by automotive demand rollover, fading tariff protection, and a retest of the $9.38-$9.95 support zone before potentially revisiting the $7.73 52-week low. The base case is most likely because it requires only that the recovery prove real but uneven — the key assumption being that the Q3 margin inflection holds at a moderate level rather than either accelerating sharply or reversing.
CLF screens as modestly undervalued on forward earnings but fairly valued on a risk-adjusted basis. The trailing PE of -4.43 is meaningless given EPS of -$0.226, so the relevant anchors are the 0.351x PS, 0.718x EV/Sales, 1.07x P/B, and 6.72x forward PE; the PS ratio sits at the very bottom of a multi-year band that reached 2.02x in Q4 2023 and 1.52x in Q4 2025, and P/B is in the lower half of its range (1.31x in Q4 2023). The market is clearly paying a discount rather than a premium, but that discount is not irrational: it prices in doubt about whether the 8.29% gross margin is a durable tariff-and-contract reset or a temporary spike, and it reflects -$485 million TTM free cash flow and -24.17% ROE. In other words, the valuation implies the market expects the recovery to fade or stall; if gross margin holds above 8% for a second quarter and the $1 billion incremental EBITDA materializes, the multiple has substantial room to re-rate, but if margins roll back toward breakeven the 6.72x forward PE offers no protection against estimate cuts.
From a risk/reward standpoint CLF is a balanced-to-slightly-attractive proposition rather than a compelling one: the $14.35 average analyst target implies roughly 25% upside from $11.46, and the 6.72x forward PE on $1.6019 consensus EPS is not stretched for an integrated steelmaker, but the downside is equally real with the $12.00 low target only about 5% above spot and the $7.73 52-week low roughly 33% below. The bull case rests on a genuine inflection — Q3 2026 net income of $152 million, 8.29% gross margin versus -1.67% in Q1, and 18.55% revenue growth — while the bear case rests on a balance sheet with 57.3% debt-to-capitalization, $148 million quarterly interest expense, and only $77 million of cash. It is a good buy primarily for risk-tolerant investors building a small cyclical position on weakness toward the $9.38-$9.95 support zone, and a poor fit for anyone needing income (0% dividend yield) or low volatility (beta 1.976). The 2 Buy / 10 Hold / 1 Sell consensus and 2.77 recommendation mean confirm that even the sell side sees value but lacks conviction on timing.
CLF is better suited to a medium-term cyclical holding than either a short-term trade or a multi-year buy-and-hold. The growth stage is a mature, capital-intensive integrated steelmaker with no dividend (0% yield, 0% payout ratio) and highly cyclical earnings visibility — Q3 2026's $0.27 EPS followed Q2's -$0.25 and Q1's -$0.42, so quarterly results swing violently and make short-term trading a bet on earnings timing rather than business quality. The 1.976 beta, 4.44 short ratio, and 16.8 million daily volume mean short-term price action is dominated by tariff headlines and sector rotation, as the 20% two-day November drawdown showed. A concrete suggested minimum holding period is 12-18 months, long enough to see whether gross margin holds above 8% across two to three quarters and whether the $1 billion incremental EBITDA and $4 billion 2027 path gain credibility, while position sizing should be materially smaller than a market-beta equivalent given the -51.67% max drawdown. Investors seeking income or low volatility should look elsewhere.